Bioxytran (BIXT) Shares Outstanding (2011 - 2026)

Bioxytran has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $113.4 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 27.54% year-over-year to $113.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $113.4 million (up 27.54% YoY) and the FY2025 annual result came in at $108.1 million, down 21.97% from the prior year.
• Shares Outstanding (Entity) grew to $113.4 million in Q1 2026 per BIXT's latest filing, from $108.1 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $177.4 million in Q2 2024 and troughed at $88.9 million in Q1 2025.
• A 5-year average of $124.5 million and a median of $123.3 million in 2022 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) jumped 40.1% in 2024, then slumped 49.84% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $123.3 million in 2022, then advanced by 18.17% to $145.6 million in 2023, then fell by 4.84% to $138.6 million in 2024, then decreased by 21.97% to $108.1 million in 2025, then gained by 4.82% to $113.4 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $113.4 million, $108.1 million, and $89.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.